194 related articles for article (PubMed ID: 38890350)
1. Tumor initiation and early tumorigenesis: molecular mechanisms and interventional targets.
Zhang S; Xiao X; Yi Y; Wang X; Zhu L; Shen Y; Lin D; Wu C
Signal Transduct Target Ther; 2024 Jun; 9(1):149. PubMed ID: 38890350
[TBL] [Abstract][Full Text] [Related]
2. Somatic variation in normal tissues: friend or foe of cancer early detection?
Acha-Sagredo A; Ganguli P; Ciccarelli FD
Ann Oncol; 2022 Dec; 33(12):1239-1249. PubMed ID: 36162751
[TBL] [Abstract][Full Text] [Related]
3. Somatic clonal evolution: A selection-centric perspective.
Scott J; Marusyk A
Biochim Biophys Acta Rev Cancer; 2017 Apr; 1867(2):139-150. PubMed ID: 28161395
[TBL] [Abstract][Full Text] [Related]
4. Cell Competition in Carcinogenesis.
Madan E; Palma AM; Vudatha V; Trevino JG; Natarajan KN; Winn RA; Won KJ; Graham TA; Drapkin R; McDonald SAC; Fisher PB; Gogna R
Cancer Res; 2022 Dec; 82(24):4487-4496. PubMed ID: 36214625
[TBL] [Abstract][Full Text] [Related]
5. Normal Somatic Mutations in Cancer Transformation.
Wijewardhane N; Dressler L; Ciccarelli FD
Cancer Cell; 2021 Feb; 39(2):125-129. PubMed ID: 33220180
[TBL] [Abstract][Full Text] [Related]
6. Recurrent driver mutations in benign tumors.
Gomes CC
Mutat Res Rev Mutat Res; 2022; 789():108412. PubMed ID: 35690415
[TBL] [Abstract][Full Text] [Related]
7. [The cause of cancer mutations: Improvable bad life or inevitable stochastic replication errors?].
Alekseenko IV; Kuzmich AI; Pleshkan VV; Tyulkina DV; Zinovyeva MV; Kostina MB; Sverdlov ED
Mol Biol (Mosk); 2016; 50(6):906-921. PubMed ID: 28064307
[TBL] [Abstract][Full Text] [Related]
8. Targeted-sequence of normal urothelium and tumor of patients with non-muscle invasive bladder cancer.
Hayashi Y; Fujita K; Sakai K; Adomi S; Banno E; Nojima S; Tomiyama E; Matsushita M; Kato T; Hatano K; Kawashima A; Minami T; Morii E; Uemura H; Nishio K; Nonomura N
Sci Rep; 2022 Oct; 12(1):16642. PubMed ID: 36198773
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of oncogenic cell competition-Paths of victory.
Gutiérrez-Martínez A; Sew WQG; Molano-Fernández M; Carretero-Junquera M; Herranz H
Semin Cancer Biol; 2020 Jun; 63():27-35. PubMed ID: 31128299
[TBL] [Abstract][Full Text] [Related]
10. Changing mutational and adaptive landscapes and the genesis of cancer.
Liggett LA; DeGregori J
Biochim Biophys Acta Rev Cancer; 2017 Apr; 1867(2):84-94. PubMed ID: 28167050
[TBL] [Abstract][Full Text] [Related]
11. Mutations, evolution and the central role of a self-defined fitness function in the initiation and progression of cancer.
Gatenby RA; Brown J
Biochim Biophys Acta Rev Cancer; 2017 Apr; 1867(2):162-166. PubMed ID: 28341421
[TBL] [Abstract][Full Text] [Related]
12. Molecular biology of oncogenic inflammatory processes. I. Non-oncogenic and oncogenic pathogens, intrinsic inflammatory reactions without pathogens, and microRNA/DNA interactions (Review).
Sinkovics JG
Int J Oncol; 2012 Feb; 40(2):305-49. PubMed ID: 22076306
[TBL] [Abstract][Full Text] [Related]
13. The dualistic origin of human tumors.
Liu J
Semin Cancer Biol; 2018 Dec; 53():1-16. PubMed ID: 30040989
[TBL] [Abstract][Full Text] [Related]
14. Clonal Hematopoiesis with Oncogenic Potential (CHOP): Separation from CHIP and Roads to AML.
Valent P; Kern W; Hoermann G; Milosevic Feenstra JD; Sotlar K; Pfeilstöcker M; Germing U; Sperr WR; Reiter A; Wolf D; Arock M; Haferlach T; Horny HP
Int J Mol Sci; 2019 Feb; 20(3):. PubMed ID: 30759825
[TBL] [Abstract][Full Text] [Related]
15. A step-by-step microRNA guide to cancer development and metastasis.
Markopoulos GS; Roupakia E; Tokamani M; Chavdoula E; Hatziapostolou M; Polytarchou C; Marcu KB; Papavassiliou AG; Sandaltzopoulos R; Kolettas E
Cell Oncol (Dordr); 2017 Aug; 40(4):303-339. PubMed ID: 28748501
[TBL] [Abstract][Full Text] [Related]
16. [Prevention of cancer and the dose-effect relationship: the carcinogenic effects of ionizing radiations].
Tubiana M
Cancer Radiother; 2009 Jul; 13(4):238-58. PubMed ID: 19539515
[TBL] [Abstract][Full Text] [Related]
17. Frequent silencing of RASSF1A via promoter methylation in follicular thyroid hyperplasia: a potential early epigenetic susceptibility event in thyroid carcinogenesis.
Brown TC; Juhlin CC; Healy JM; Prasad ML; Korah R; Carling T
JAMA Surg; 2014 Nov; 149(11):1146-52. PubMed ID: 25229773
[TBL] [Abstract][Full Text] [Related]
18. Tissue disruption increases stochastic gene expression thus producing tumors: Cancer initiation without driver mutation.
Capp JP
Int J Cancer; 2017 Jun; 140(11):2408-2413. PubMed ID: 28052327
[TBL] [Abstract][Full Text] [Related]
19. Iatrogenic endometriosis harbors somatic cancer-driver mutations.
Lac V; Verhoef L; Aguirre-Hernandez R; Nazeran TM; Tessier-Cloutier B; Praetorius T; Orr NL; Noga H; Lum A; Khattra J; Prentice LM; Co D; Köbel M; Mijatovic V; Lee AF; Pasternak J; Bleeker MC; Krämer B; Brucker SY; Kommoss F; Kommoss S; Horlings HM; Yong PJ; Huntsman DG; Anglesio MS
Hum Reprod; 2019 Jan; 34(1):69-78. PubMed ID: 30428062
[TBL] [Abstract][Full Text] [Related]
20. Enigmas in tumor resistance to kinase inhibitors and calculation of the drug resistance index for cancer (DRIC).
Smith CIE
Semin Cancer Biol; 2017 Aug; 45():36-49. PubMed ID: 27865897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
